Actively Recruiting
The GEOLynch Cohort Study
Led by Wageningen University · Updated on 2017-10-06
1000
Participants Needed
1
Research Sites
1274 weeks
Total Duration
On this page
Sponsors
W
Wageningen University
Lead Sponsor
W
Wereld Kanker Onderzoek Fonds
Collaborating Sponsor
AI-Summary
What this Trial Is About
The GEOLynch cohort study has been established to investigate the influence of genetic, environmental and other factors on tumour risk in persons with Lynch syndrome.
CONDITIONS
Official Title
The GEOLynch Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Persons with a known mutation in a gene that causes Lynch syndrome, i.e. with an inherited monoallelic pathogenic germline mutation in either the MLH1, MSH2, MSH6, PMS2 or EPCAM gene.
- Aged between 18 and 80 years at inclusion.
You will not qualify if you...
- Additional carrier of another hereditary colon cancer predisposition syndrome (e.g. FAP)
- (Chronic) Inflammatory bowel disease
- Non-Dutch speaking
- Dementia or another mental condition that makes it impossible to fill out questionnaires
- Terminally ill persons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wageningen University
Wageningen, Netherlands
Actively Recruiting
Research Team
F
Fränzel van Duijnhoven, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here